China’s NMPA has satri-cel for pretreated, CLDN18.2-positive, HER2-negative advanced gastric/GEJ adenocarcinoma.
Commentary|Videos|August 26, 2024
Gene and Cell Therapy: Shaping the Future of Medicine
Author(s)Marco Davila, MD, PhD
Marco Davila, MD, PhD, discusses how to shape the future of medicine with gene and cell therapy.
Advertisement
Marco Davila, MD, PhD, discusses how to shape the future of medicine with gene and cell therapy.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on OncLive
1
Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera
2
The OncFive: Top Oncology Articles for the Week of 6/28
3
Luspatercept Sustains Long-Term Transfusion Independence, Favorable OS Trend in ESA-Naive Lower-Risk MDS
4
FDA Grants Breakthrough Device Designation to Merlin CP-GEP for Early-Stage Melanoma Risk Stratification
5